New variant causes more symptoms
January 27, 2021
300,158
9,188
2,947
4.04%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dr John Campbell Episodes Around January 27, 2021
See what was published immediately before and after this episode.
30:53Now PlayingNew variant causes more symptoms
YouTube Description
as posted by the channelCoronavirus (COVID-19) Infection Survey: characteristics of people testing positive for COVID-19 in England, 27 January 2021
Antigen survey
S-gene is no longer detected in the current test
Classic symptoms
Cough, fever, shortness of breath, loss of taste or loss of smell
New UK variant infections
Were more likely to report any symptoms
Largest difference, more reports of cough, sore throat, fatigue, myalgia, fever
More likely to report the classic symptoms
Significantly less likely to report loss of taste and smell
There is no evidence of difference in the gastrointestinal symptoms, shortness of breath or headaches.
UK
Cases, + 25,308 = 3,715,054
Hospitalisations, 3,082 = 37,605 (3,961)
Deaths, + 1,631 + 1,725 = 101,887
Deaths, + 7,766 = 103,602
Deaths will come down slowly
Prof Chris Whitty
a lot more deaths over the next few weeks
before the effects of vaccinations kick in
Current restrictions just about holding in lowering infection rates
Vaccinations
First dose, 7,164,387
Second dose, 474,156
Earliest English school return date, 8th March
UK travel
Quarantine in hotels, 10 days
30 high risk countries
Met at airport transported directly into quarantine
South America, South Africa, Portugal travellers already banned
Ban on travel for leisure
US, CDC data
Past 7 days
Cases, down 16.4%
Deaths, up 10.4%
Hospitalizations, down 10.4%
Positivity rate, 9.1%
Vaccinations
24,391,000 doses given
Completed courses, 3,529,000 (1.08%)
China
Anal swab as a potentially optimal specimen for SARS-CoV-2 detection to evaluate hospital discharge of COVID-19 patients (Future Medicine)
ACE2 is most abundantly expressed on the surface of alveolar epithelial cells and small intestine epithelial cells
SARS-CoV-2 shed in the different phases of infection
Betacoronavirus genus, can cause respiratory, intestinal, liver and nervous system infections in animals and humans
Recovering patients
Continued to test positive days after nasal and throat swabs were negative
Quarantine centers
Raise rate of identifying infected patients
Domestic travel
Lunar New Year next month
Travelers arriving from overseas
Two weeks of hotel quarantine
Plus a third week of home quarantine
Fourth week of daily reports to health officials
EU, Oxford AZ vaccine
Not yet approved by EMA
August ordered 300 million (+ 100 m) doses
Production delays, plants, Netherlands and Belgium
Two months behind
UK deal signed May
80 million doses expected by March
Reduced to 31 million, down 60% for first quarter
EU has threatened to restrict vaccine exports
EU, Pfizer/BioNTech
Order, 600 m doses
Delayed supplies for a few weeks
Sanofi will help produce 125 million doses in Frankfurt from July
Global vaccine tracker
UK vaccine tracker
US vaccine tracker
Europe vaccine tracker
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.